United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2018_register executive 2019-04-02 article Notices D09002ee1c7dd5742 D09002ee1c7dd59a3 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Summary Information section of this notice to Fundacao Butantan (Butantan), having a place of business in Sao Paulo, Brazil. 83 FR 65697 https://www.govinfo.gov/app/details/FR-2018-12-21/2018-27673 2018-27673 fr21de18-118 4140-01-P https://www.govinfo.gov/app/details/FR-2018-12-21/2018-27673 https://www.govinfo.gov/content/pkg/FR-2018-12-21/html/2018-27673.htm https://www.govinfo.gov/content/pkg/FR-2018-12-21/pdf/2018-27673.pdf 2 p. 65697 65698 83 FR 65697 Prospective Grant of Exclusive Patent License: Production of Monovalent Live Attenuated Zika Vaccines and Multivalent Live Attenuated Zika and Dengue Vaccines; Federal Register Vol. 83, Issue NOTICE 2018-27673 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2019-01-22 4140-01-P 2018-27673 Notice.

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Summary Information section of this notice to Fundacao Butantan (Butantan), having a place of business in Sao Paulo, Brazil.

Only written comments and/or applications for a license which are received by the National Institute of Allergy and Infectious Diseases' Technology Transfer and Intellectual Property Office on or before January 22, 2019 will be considered. Prospective Grant of Exclusive Patent Licenses: Production of Monovalent Live Attenuated Zika Vaccines and Multivalent Live Attenuated Zika and Dengue Vaccines , ps193c@nih.gov https://www.phe.gov/Preparedness/planning/Pages/zika-white-paper.aspx Vol. 83, no. 245 Office of the Federal Register, National Archives and Records Administration 2018-12-21 continuing daily deposited born digital 603 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2018-12-21 P0b002ee1a03a903e 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr21de18 https://www.govinfo.gov/app/details/FR-2018-12-21 https://www.govinfo.gov/content/pkg/FR-2018-12-21/pdf/FR-2018-12-21.pdf https://www.govinfo.gov/content/pkg/FR-2018-12-21/xml/FR-2018-12-21.xml fdlp 65481 66075 DGPO 2019-04-02 2024-05-31 FR-2018-12-21 machine generated eng FR FR-2018-12-21 83 245